Your browser doesn't support javascript.
loading
[Pharmacoeconomic advantages of recombinant FSH vs urinary derived FSH]. / Avantages pharmaco-économiques de la FSH d'origine recombinante par rapport à la FSH d'origine urinaire.
Beresniak, A.
Affiliation
  • Beresniak A; Serono international SA, 15, chemin des Mines, CH 1211, Genève 20, Suisse. ariel.beresniak@serono.com
Gynecol Obstet Fertil ; 32(9): 756-9, 2004 Sep.
Article in Fr | MEDLINE | ID: mdl-15380758
Subject(s)
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Economics, Pharmaceutical / Follicle Stimulating Hormone Type of study: Health_economic_evaluation / Prognostic_studies Limits: Female / Humans / Pregnancy Language: Fr Journal: Gynecol Obstet Fertil Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2004 Type: Article Affiliation country: Switzerland
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Economics, Pharmaceutical / Follicle Stimulating Hormone Type of study: Health_economic_evaluation / Prognostic_studies Limits: Female / Humans / Pregnancy Language: Fr Journal: Gynecol Obstet Fertil Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2004 Type: Article Affiliation country: Switzerland